Atlas Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $429K | Sell |
1,185
-5,540
| -82% | -$1.9M | 0.05% | 309 |
|
|
2026
Q1 | $2.37M | Hold |
6,725
| – | – | 0.27% | 83 |
|
|
2025
Q4 | $2.2M | Buy |
+6,725
| New | +$2.13M | 0.25% | 92 |
|
|
2025
Q2 | $1.88M | Sell |
6,721
-31
| -0.5% | -$8.78K | 0.23% | 90 |
|
|
2025
Q1 | $2.1M | Hold |
6,752
| – | – | 0.26% | 80 |
|
|
2024
Q4 | $1.76M | Buy |
6,752
+5,537
| +456% | +$1.64M | 0.22% | 85 |
|
|
2024
Q3 | $391K | Sell |
1,215
-5,455
| -82% | -$1.78M | 0.06% | 269 |
|
|
2024
Q2 | $2.08M | Buy |
6,670
+5,289
| +383% | +$1.55M | 0.27% | 78 |
|
|
2024
Q1 | $393K | Sell |
1,381
-5,524
| -80% | -$1.62M | 0.06% | 259 |
|
|
2023
Q4 | $1.99M | Hold |
6,905
| – | – | 0.29% | 67 |
|
|
2023
Q3 | $1.86M | Buy |
6,905
+100
| +1% | +$25K | 0.31% | 65 |
|
|
2023
Q2 | $1.51M | Sell |
6,805
-13
| -0.2% | -$3.02K | 0.23% | 82 |
|
|
2023
Q1 | $1.65M | Sell |
6,818
-14
| -0.2% | -$3.44K | 0.26% | 73 |
|
|
2022
Q4 | $1.79M | Sell |
6,832
-254
| -4% | -$68.1K | 0.3% | 66 |
|
|
2022
Q3 | $1.6M | Buy |
7,086
+13
| +0.2% | +$3.15K | 0.29% | 67 |
|
|
2022
Q2 | $1.72M | Sell |
7,073
-34
| -0.5% | -$8.33K | 0.29% | 70 |
|
|
2022
Q1 | $1.72M | Buy |
7,107
+79
| +1% | +$18.2K | 0.27% | 84 |
|
|
2021
Q4 | $1.58M | Sell |
7,028
-250
| -3% | -$52.8K | 0.24% | 87 |
|
|
2021
Q3 | $1.55M | Sell |
7,278
-300
| -4% | -$69K | 0.25% | 84 |
|
|
2021
Q2 | $1.85M | Buy |
7,578
+31
| +0.4% | +$7.63K | 0.31% | 76 |
|
|
2021
Q1 | $1.88M | Buy |
7,547
+250
| +3% | +$59.7K | 0.37% | 64 |
|
|
2020
Q4 | $1.68M | Hold |
7,297
| – | – | 0.35% | 65 |
|
|
2020
Q3 | $1.85M | Sell |
7,297
-290
| -4% | -$71.8K | 0.44% | 48 |
|
|
2020
Q2 | $1.79M | Sell |
7,587
-58
| -0.8% | -$13.2K | 0.42% | 54 |
|
|
2020
Q1 | $1.55M | Hold |
7,645
| – | – | 0.46% | 46 |
|
|
2019
Q4 | $1.84M | Hold |
7,645
| – | – | 0.46% | 53 |
|
|
2019
Q3 | $1.48M | Buy |
7,645
+213
| +3% | +$40.9K | 0.44% | 58 |
|
|
2019
Q2 | $1.37M | Sell |
7,432
-28
| -0.4% | -$5.01K | 0.45% | 55 |
|
|
2019
Q1 | $1.42M | Buy |
7,460
+28
| +0.4% | +$5.35K | 0.51% | 51 |
|
|
2018
Q4 | $1.45M | Hold |
7,432
| – | – | 0.58% | 41 |
|
|
2018
Q3 | $1.54M | Hold |
7,432
| – | – | 0.51% | 45 |
|
|
2018
Q2 | $1.44M | Hold |
7,432
| – | – | 0.51% | 46 |
|
|
2018
Q1 | $1.27M | Buy |
+7,432
| New | +$1.36M | 0.39% | 73 |
|
Other funds holding AMGN
Atlas Capital Advisors's AMGN Position: Q2 2026 in Review
Atlas Capital Advisors reduced its Amgen (AMGN) stake by 82% in Q2 2026, selling an estimated $1.9M and leaving 1,185 shares worth $429K. The position accounts for 0.05% of the portfolio, ranked #309.
Atlas Capital Advisors first reported a position in AMGN in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.37M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Atlas Capital Advisors held 1,185 shares of Amgen worth $429K as of Q2 2026.
- Atlas Capital Advisors sold 5,540 Amgen shares in Q2 2026, an estimated $1.9M.
- Amgen made up 0.05% of Atlas Capital Advisors's portfolio in Q2 2026, its #309 holding.
- Atlas Capital Advisors first reported a position in Amgen in Q1 2018 and has held it in 33 quarters since.
- Atlas Capital Advisors's Amgen position peaked at $2.37M in Q1 2026.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.